Plasma CCN2 is independently related to subsequent need for abdominal aorta aneurysm repair

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

The objective of this study was to determine if plasma CCN2 is associated with abdominal aorta aneurysm (AAA), and future need for AAA repair, and further to assess the potential clinical value of CCN2 in predicting disease outcome. CCN2 was quantified in plasma samples obtained from a cohort of 679 men aged 65–74 at initial ultrasound screening for AAA in the Viborg Vascular (VIVA) screening trial. Plasma CCN2 was correlated with need for future surgical repair in the whole study population (HR = 1.457 (1.081–1.962), p =.013) and in the AAA group alone (HR = 1.431 (1.064–1.926), p =.018), yet the predictive value (CCN2 > 0 and <0 of 0.52 and 0.55, respectively) disqualified its use in clinically relevant AAA repair prediction. In conclusion, CCN2 is independently related to subsequent need for AAA repair, but has negligible predictive power for clinical use.

Original languageEnglish
JournalGrowth Factors
Volume37
Issue number3-4
Pages (from-to)146-152
ISSN0897-7194
DOIs
Publication statusPublished - 6. Sep 2019

Keywords

  • Abdominal Aortic Aneurysm
  • CCN2
  • VIVA Trial

Fingerprint Dive into the research topics of 'Plasma CCN2 is independently related to subsequent need for abdominal aorta aneurysm repair'. Together they form a unique fingerprint.

Cite this